rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2004-8-13
|
pubmed:abstractText |
A recent retrospective study suggested that the adenosine monophosphate deaminase (AMPD)-1 gene variant C34T predicts outcome in heart failure patients. This variant might lead to ischemic preconditioning by increasing tissue adenosine. We tested whether the survival benefit of C34T occurs preferentially in the setting of ischemic left ventricular dysfunction.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1071-9164
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
316-20
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15309698-AMP Deaminase,
pubmed-meshheading:15309698-Adult,
pubmed-meshheading:15309698-Aged,
pubmed-meshheading:15309698-Alleles,
pubmed-meshheading:15309698-Disease-Free Survival,
pubmed-meshheading:15309698-Female,
pubmed-meshheading:15309698-Follow-Up Studies,
pubmed-meshheading:15309698-Gene Frequency,
pubmed-meshheading:15309698-Genetic Predisposition to Disease,
pubmed-meshheading:15309698-Genotype,
pubmed-meshheading:15309698-Heart Transplantation,
pubmed-meshheading:15309698-Humans,
pubmed-meshheading:15309698-Male,
pubmed-meshheading:15309698-Middle Aged,
pubmed-meshheading:15309698-Multivariate Analysis,
pubmed-meshheading:15309698-Myocardial Ischemia,
pubmed-meshheading:15309698-Predictive Value of Tests,
pubmed-meshheading:15309698-Stroke Volume,
pubmed-meshheading:15309698-Time Factors,
pubmed-meshheading:15309698-Ventricular Dysfunction, Left
|
pubmed:year |
2004
|
pubmed:articleTitle |
A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunction.
|
pubmed:affiliation |
Cardiovascular Department, LDS Hospital, Salt Lake City, Utah 84143, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|